Hematological Malignancies Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Recruiting
  • Hematological Malignancies
  • Pembrolizumab/vibostolimab coformuation
  • Duarte, California
  • +44 more
2022-04-01
Apr 1, 2022
A
Active, not recruiting
  • CD20-Positive Lymphoid Malignancies
  • +3 more
  • Tucson, Arizona
  • +5 more
2022-03-22
Mar 22, 2022
C
Not yet recruiting
  • Solid Tumor
  • Hematological Malignancies
  • NiCE
  • Routine PPC
  • Shanghai, Minhang, China
    Children's Hospital of Fudan University
2022-03-29
Mar 29, 2022
G
Recruiting
  • Hematological Malignancies
  • omidubicel
  • Los Angeles, California
  • +5 more
2022-03-31
Mar 31, 2022
A
Recruiting
  • Pediatric Cancer
  • +2 more
  • Durvalumab / Tremelimumab Combination Therapy
  • Baltimore, Maryland
  • +22 more
2022-03-14
Mar 14, 2022
J
Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +73 more
2022-03-24
Mar 24, 2022
J
Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +14 more
2022-03-24
Mar 24, 2022
J
Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +77 more
2022-03-24
Mar 24, 2022
U
Active, not recruiting
  • Graft-Versus-Host Disease
  • Hematological Malignancies
  • Antwerpen,, Antwerpen, Belgium
  • +12 more
2022-03-22
Mar 22, 2022
N
Recruiting
  • Hematological Malignancies
  • Hematopoietic Stem Cell Transplantation
  • PBSCs
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
2022-03-13
Mar 13, 2022
D
Recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • +8 more
    • Boston, Massachusetts
    • +1 more
    2022-03-15
    Mar 15, 2022
    S
    Recruiting
    • Hematological Malignancies
    • Total Body Irradiation
    • +6 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    2022-02-04
    Feb 4, 2022
    G
    Active, not recruiting
    • Hematological Malignancies
    • Duarte, California
    • +26 more
    2022-02-03
    Feb 3, 2022
    U
    Completed
    • Hematological Malignancies
    • Conditioning regimen: TBI + Fludarabine
    • Conditioning regimen:TLI (8 Gy) + ATG
    • Leuven, Flamish Brabant, Belgium
    • +10 more
    2021-11-16
    Nov 16, 2021
    M
    A
    Completed
    • Hematological Malignancies
    • Boston, Massachusetts
    • +1 more
    2021-10-19
    Oct 19, 2021
    F
    Completed
    • Hematological Malignancies
    • Haploidentical Stem Cell Transplantation
    • no intervention
    • Hangzhou, Zhejiang, China
    • +1 more
    2021-10-22
    Oct 22, 2021
    R
    Enrolling by invitation
    • Hematological Malignancies
    • San Francisco, California
    • +6 more
    2021-11-01
    Nov 1, 2021
    S
    Active, not recruiting
    • Hematological Malignancies
    • Durham, North Carolina
      Duke University of Medicine
    2021-10-19
    Oct 19, 2021
    T
    Active, not recruiting
    • Hematological Malignancies
      • Tampere, Finland
        Tampere Univerisity Hospital
      2021-09-30
      Sep 30, 2021
      C
      Recruiting
      • Hematological Malignancies
      • TQB3820 tablets
      • Beijing, Beijing, China
      • +1 more
      2021-09-18
      Sep 18, 2021
      A
      Completed
      • Solid Tumors
      • Hematological Malignancies
      • Belinostat IV
      • Santa Monica, California
      • +2 more
      2021-09-10
      Sep 10, 2021
      O
      Active, not recruiting
      • Immunogenicity
      • +3 more
        • Varese, Lombardia, Italy
          UOC Ematologia, ASST Sette Laghi, Osp. Di Circolo e Fondazione M
        2021-09-10
        Sep 10, 2021
        M
        Enrolling by invitation
        • Monoclonal Gammopathy of Undetermined Significance
        • +6 more
          • Milwaukee, Wisconsin
            Aurora Health Care
          2021-07-20
          Jul 20, 2021